Suxamethonium induced prolonged apnea in a patient receiving electroconvulsive therapy.
Suxamethonium causes prolonged apnea in patients in whom pseudocholinesterase enzyme gets deactivated by organophosphorus (OP) poisons. Here, we present a similar incident in a severely depressed patient who received electroconvulsive therapy (ECT). Prolonged apnea in our case ensued because the information about suicidal attempt by OP compound was concealed from the treating team.
Waghmare
Avinash
A
Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore 560002, India.
Kumar
Channaveerachari Naveen
CN
Thirthalli
Jagadisha
J
D000328:Adult; D001049:Apnea / Q000139:chemically induced*; D002389:Catatonia / Q000628:therapy; D003865:Major Depressive Disorder / Q000628:therapy; D004347:Drug Interactions; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects*; D062025:Organophosphate Poisoning; D013390:Succinylcholine / Q000009:adverse effects*; D013406:Suicide, Attempted
D009467:Neuromuscular Depolarizing Agents; D013390:Succinylcholine